FDA, Networking and Pharmaceutical research

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

FDA

Networking

Pharmaceutical research

Dawn of a new indication: how to study drugs for aging

Pharmaceutical Technology

MARCH 6, 2023

Currently, most drugs being investigated for their healthy aging or anti-aging properties are being repurposed from readily accessible FDA-approved drugs. Barzilai hopes that the well-established profile of the drug may allow the FDA to accept the trial more easily and then other aging-related studies can follow.

FDA

FDA Pharmaceutical Prospecting Medicine

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

SEPTEMBER 22, 2023

Limitations of monoclonal antibody therapies Regulatory approvals from the US Food and Drug Administration (FDA) for aducanumab and lecanemab – and likely very soon for donanemab also – opened a route for different therapeutic modalities and other relevant disease targets, such as tau.

Food and Drug Administration

Food and Drug Administration Safety Patients Leads

Pharma Rep Focus

Dawn of a new indication: how to study drugs for aging

Paving the way for anti-Abeta active immunotherapy

Stay Connected